04:49 PM EDT, 08/23/2024 (MT Newswires) -- ARCA biopharma (ABIO) said Friday its board approved a 1-for-12 reverse stock split of its shares.

The shares will start trading on a split-adjusted basis on Sept. 3 under the new name, Oruka Therapeutics, and under the new symbol "ORKA" following the expected closing of its merger with Oruka, the firm said.

Price: 4.3400, Change: +0.18, Percent Change: +4.33